plaque psoriasis

COSENTYX® (secukinumab) for injection

COSENTYX® (secukinumab) for injection

Secukinumab is a recombinant human monoclonal IgG1/κ antibody that binds specifically to IL-17A. COSENTYX is a human interleukin-17A antagonist indicated for the treatment of moderate to severe plaque psoriasis, active psoriatic arthritis and active ankylosing spondylitis

CIMZIA (certolizumab pegol) for injection

Certolizumab pegol is a TNF blocker. CIMZIA is a recombinant, humanized antibody Fab’ fragment, with specificity for human tumor necrosis factor alpha (TNFα), conjugated to an approximately 40kDa polyethylene glycol (PEG2MAL40K).